Vered Stearns

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.742Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772

Top 27%

0.742DataRank

Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Papers

Driven by 38 papers — median percentile 73. Top paper: “Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030”.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of Oncology(2023)10.1016/j.annonc.2023.08.004

N/A

1.7DataRank · unranked

58 citations

Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772

Top 27%

0.742DataRank

Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer

Frontiers in Physiology(2020)10.3389/fphys.2020.583333

N/A

0.659DataRank · unranked

80 citations

Chang Gong, Jeremias Sulam, Elana J. Fertig, Alexander S. Szalay, Elizabeth M. Jaffee +5 more

Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0170

N/A

0.624DataRank · unranked

63 citations

Christine I. Rafie, Julie K. Jang, Sofi Castanon, Aaron G. Baugh, Edgar Gonzalez +21 more

Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?

Expert Reviews in Molecular Medicine(2008)10.1017/s1462399408000896

N/A

0.612DataRank · unranked

58 citations

James M. Rae, Vered Stearns

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

Nature Cancer(2024)10.1038/s43018-024-00729-w

N/A

0.587DataRank · unranked

49 citations

Won Jin Ho, Ludmila Danilova, Joseph A. Tandurella, James M. Leatherman, Christine I. Rafie +22 more

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

Frontiers in Genetics(2021)10.3389/fgene.2021.662734

N/A

0.574DataRank · unranked

14 citations

Karen L. Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman +6 more

Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06750-w

N/A

0.569DataRank · unranked

6 citations

Amanda L. Blackford, Elissa Thorner, Jennifer Lehman, Claire Snyder, Vered Stearns +2 more

Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-5017

N/A

0.538DataRank · unranked

35 citations

Christine I. Rafie, Chenguang Wang, David Lim, Adam Brufsky, Patricia LoRusso +16 more

Forecasting cancer: from precision to predictive medicine

Med(2021)10.1016/j.medj.2021.08.007

N/A

0.515DataRank · unranked

30 citations

Elizabeth M. Jaffee, Paul Macklin, Vered Stearns, Chenguang Wang, Elana J. Fertig

Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12001

N/A

0.360DataRank · unranked

10 citations

Karla V. Ballman, Linda McCall, Pamela J. Goodwin, Anna Weiss, Linda M. Delahanty +15 more

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2137

N/A

0.330DataRank · unranked

8 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion

JCO Precision Oncology(2024)10.1200/po.24.00254

N/A

0.284DataRank · unranked

5 citations

Jaime Wehr, Katerina Karaindrou, Rena R. Xian, Christopher D. Gocke, Ming‐Tseh Lin +35 more

Exploring the links of skeletal muscle mitochondrial oxidative capacity, physical functionality, and mental well-being of cancer survivors

Scientific Reports(2024)10.1038/s41598-024-52570-x

N/A

0.208DataRank · unranked

3 citations

Leorey N. Saligan, Christopher M. Bergeron, Philip R. Lee, Kenneth W. Fishbein, Richard G. Spencer +8 more

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07519-z

N/A

0.174DataRank · unranked

2 citations

Anne O’Neill, Bryan P. Schneider, Todd C. Skaar, Minetta C. Liu, Caroline Lohrisch +9 more

Late effects in a high-risk population of breast cancer survivors

Supportive Care in Cancer(2021)10.1007/s00520-021-06597-9

N/A

0.165DataRank · unranked

2 citations

Sarah Skuli, Elissa Thorner, Nelli Zafman, Carol Riley, Jessica M. Ruck +6 more

Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12003

N/A

0.165DataRank · unranked

2 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

Overall side‐effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

Cancer(2025)10.1002/cncr.70084

N/A

0.165DataRank · unranked

2 citations

Shaili Ganatra, Fengmin Zhao, Ju‐Whei Lee, Jessica Roydhouse, Edward H. Ip +13 more

Innovating and expanding weight loss strategies for breast cancer survivors

Oncotarget(2021)10.18632/oncotarget.27898

N/A

0.165DataRank · unranked

2 citations

Vered Stearns, Jennifer Y. Sheng

Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors

Frontiers in Bioengineering and Biotechnology(2020)10.3389/fbioe.2020.00141

N/A

0DataRank · unranked

52 citations

Richard J. Sové, Mohammad Jafarnejad, Sondra Rahmeh, Elizabeth M. Jaffee, Vered Stearns +4 more

Data from Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

(2023)10.1158/1078-0432.c.6523959

N/A

0DataRank · unranked

0 citations

Amanda L. Blackford, Anne Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich +12 more

Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation

JAMIA Open(2024)10.1093/jamiaopen/ooae006

N/A

0DataRank · unranked

1 citations

Vered Stearns, Amanda L. Blackford, Daniel L. Hertz, Karen L. Smith, James M. Rae +2 more

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931

N/A

0DataRank · unranked

2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

UNC Libraries(2020)10.17615/bgrr-9v25

N/A

0DataRank · unranked

0 citations

Anna Maria Storniolo, Vered Stearns, Vandana G. Abramson, Joel S. Parker, Catherine Van Poznak +19 more

Management of hormone receptor-positive, HER2-negative early breast cancer

Seminars in Oncology(2020)10.1053/j.seminoncol.2020.05.010

N/A

0DataRank · unranked

54 citations

Karen L. Smith, Vered Stearns, Elaine M. Walsh

Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers

American Society of Clinical Oncology Educational Book(2021)10.1200/edbk_320595

N/A

0DataRank · unranked

24 citations

Prudence A. Francis, Antonio Di Meglio, Vered Stearns, Inês Vaz-Luís

Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes

Clinical Breast Cancer(2021)10.1016/j.clbc.2021.12.007

N/A

0DataRank · unranked

15 citations

Neha Mangini, John H. Fetting, Deborah K. Armstrong, Isaac S. Chan, Roisín M. Connolly +13 more

The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote

Journal of Cancer Survivorship(2021)10.1007/s11764-021-01049-z

N/A

0DataRank · unranked

12 citations

Cesar A. Santa‐Maria, Amanda L. Blackford, David Lim, Ashley Carpenter, Karen L. Smith +6 more

The impact of weight loss on physical function in overweight or obese breast cancer survivors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12053

N/A

0DataRank · unranked

3 citations

Cesar Augusto Santa-Maria, Amanda L. Blackford, David Lim, Ashley Carpenter, Karen L. Smith +6 more

The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting

Expert Opinion on Therapeutic Targets(2022)10.1080/14728222.2022.2170779

N/A

0DataRank · unranked

27 citations

Vered Stearns, Cesar A. Santa‐Maria, Aleksander S. Popel, Natsuki Furukawa

Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

npj Breast Cancer(2022)10.1038/s41523-022-00414-0

N/A

0DataRank · unranked

28 citations

Neha Verma, Amanda L. Blackford, Jennifer Lehman, Kelly Westbrook, David K. Lim +15 more

Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow

Frontiers in Oncology(2022)10.3389/fonc.2022.1007874

N/A

0DataRank · unranked

13 citations

Steven P. Rowe, Vered Stearns, Roisín M. Connolly, Christos Vaklavas, Minetta C. Liu +5 more

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms

Research Square(2022)10.21203/rs.3.rs-1315678/v1

N/A

0DataRank · unranked

5 citations

Julie A. Douglas, Robert M. Miller, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta +7 more

Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12094

N/A

0DataRank · unranked

0 citations

John Devin Peipert, Vered Stearns, Victor T. Chang, Opeyemi A. Jegede, Edward H. Ip +15 more

Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6568

N/A

0DataRank · unranked

0 citations

Kelley M. Kidwell, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, N. Lynn Henry +1 more

Factors Associated with Worsening Sexual Function During Adjuvant Endocrine Therapy in a Prospective Clinic-Based Cohort of Women with Early Stage Breast Cancer

Research Square(2022)10.21203/rs.3.rs-1685371/v1

N/A

0DataRank · unranked

0 citations

Amanda L. Blackford, Elissa Thorner, Jennifer Lehman, Claire Snyder, Vered Stearns +2 more

Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.525

N/A

0DataRank · unranked

0 citations

Lauren Lenz, Elizabeth S. Cogan, Erica L. Mayer, Virginia Kaklamani, Vered Stearns +15 more

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

OncoImmunology(2020)10.1080/2162402x.2020.1760685

N/A

0DataRank · unranked

20 citations

Akash Patil, Christine I. Rafie, Brian J. Christmas, Niranjan B. Pandey, Vered Stearns +4 more

Vered Stearns

Indexed papers

Top data-sharing exemplar

Papers